SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007932
Filing Date
2019-08-12
Accepted
2019-08-12 06:12:24
Documents
53
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mlnd-20190630x10q.htm 10-Q 2262555
2 EX-10.1 mlnd-20190630ex1019b7ff8.htm EX-10.1 142742
3 EX-10.2 mlnd-20190630ex102bc53c8.htm EX-10.2 122898
4 EX-10.3 mlnd-20190630ex103d82834.htm EX-10.3 129304
5 EX-10.4 mlnd-20190630ex104d45207.htm EX-10.4 683051
6 EX-10.7 mlnd-20190630ex107cfce16.htm EX-10.7 105552
7 EX-10.8 mlnd-20190630ex108da3c00.htm EX-10.8 85599
8 EX-31.1 mlnd-20190630ex3110fd4fc.htm EX-31.1 10347
9 EX-31.2 mlnd-20190630ex31276c9b2.htm EX-31.2 10277
10 EX-32.1 mlnd-20190630ex321aa9ffd.htm EX-32.1 9332
  Complete submission text file 0001558370-19-007932.txt   6338859

Data Files

Seq Description Document Type Size
11 EX-101.INS mlnd-20190630.xml EX-101.INS 713533
12 EX-101.SCH mlnd-20190630.xsd EX-101.SCH 25618
13 EX-101.CAL mlnd-20190630_cal.xml EX-101.CAL 42305
14 EX-101.DEF mlnd-20190630_def.xml EX-101.DEF 77804
15 EX-101.LAB mlnd-20190630_lab.xml EX-101.LAB 324135
16 EX-101.PRE mlnd-20190630_pre.xml EX-101.PRE 217842
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 191014323
SIC: 2834 Pharmaceutical Preparations